Navigation Links
Springer to publish the Cerebellum
Date:3/27/2008

Springer and the Society for Research on the Cerebellum (SRC) will partner to publish the journal The Cerebellum with effect from Volume 7, March 2008. The journal represents a significant and original addition to Springers neuroscience portfolio.

The Cerebellum is a quarterly, international journal devoted to the science of the cerebellum and its role in ataxia and other medical disorders. Areas of particular interest include fundamental neurosciences (including molecular and cellular biology), behavioral neurosciences and neurochemistry, genetics, fundamental and clinical neurophysiology, neurology and neuropathology, cognition and neuroimaging.

Editor-in-Chief Mario Manto of the Universit Libre de Bruxelles said, The cerebellum contains more neurons than all the other regions of the brain. As a result of the ageing population, diseases associated with cerebellar dysfunction are becoming more widespread. The Cerebellum offers a forum for the vast amount of scientific research being done in this area. Springers publishing expertise will help to further enhance the journals profile and availability.

Ann Avouris, Publishing Editor, Biomedical Sciences, at Springer, said, Springer is pleased to welcome The Cerebellum to its neuroscience journals program. Our online information platform SpringerLink, with features such as Online First, Cross Reference Linking and Table of Content Alerts, will ensure that readers are kept fully up to date in this crucial and rapidly growing area of research.

The Cerebellum publishes reviews, original research, short communications, opinion and controversies, case studies, meeting reports and book reviews. Springer offers authors, editors and reviewers the use of a fully web-enabled online manuscript submission and review system. This system gives users the option of tracking the progress of the review process of manuscripts in real time. In addition, all authors, via the Springer Open Ch
'/>"/>

Contact: Joan Robinson
joan.robinson@springer.com
49-622-148-78130
Springer
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Springer to publish new journal focusing on ethical issues in neuroscience
2. Springer to publish International Journal of Hematology
3. Springer to launch new journal in emergency medicine
4. Springer to publish new society journal in cardiology
5. Springer launches Springer Protocols
6. Springer publishes La Chirurgia degli Organi de Movimento
7. Springer founds new electronic journal Head and Neck Pathology
8. Springer launches new journal in musculoskeletal medicine
9. Springer to publish Sports Engineering
10. Springer adds Advances in Therapy to journals portfolio
11. eMPR Digital Drug Reference Reaches 50,000 Downloads and the Publisher Launches a Raffle for Healthcare Providers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... Pittsburgh, PA (PRWEB) August 30, 2014 "I ... beach because of her crutches," said an inventor from Wetumpka, ... the sights and sounds of the shore, I came up ... beach sand." , She created a prototype for the patent-pending ... The accessory enables the individual to use crutches, walkers, or ...
(Date:8/30/2014)... In today’s world, a good night’s sleep has become ... apnea (a medical problem where the airway collapses during sleep ... the rest they need to face their daily challenges. ... million people in the United States alone have sleep apnea. ... of those treated, many cannot tolerate their prescribed medical device ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 One of the ... era is the gluten-free diet. Originally meant for sufferers of ... a catchall for people who are looking to get healthier ... not only is this kind of information erroneous, it also ... problems because of a drastic change in their food ...
(Date:8/30/2014)... Denver, Colorado (PRWEB) August 30, 2014 The ... Gut Cure program was created by Karen Brimeyer, who wanted ... the world. , This guide is now easy to ... for instant download. In this guide, the author of the ... gut cure. , Daily Gossip writes in its review ...
(Date:8/30/2014)... August 28th, 2014: With the prevalence ... and the toll that takes on the individual as ... education for physical therapists addresses this problem. , In ... others, Hands-On Seminars is offering discounts on their continuing ... styles are available to fit the individual needs of ...
Breaking Medicine News(10 mins):Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:“What is Gluten: Three Things You Need to Know Before Adopting a Gluten-Free Diet” Reveals What Readers Need to Know About the Benefits of a Strict Gluten Diet - Vinamy 2Health News:Leaky Gut Cure Review Reveals Unique Method to Stop Chronic Symptoms 2Health News:Leader in Manual Therapy Continuing Education Makes it Easier for Physical Therapists to Improve Results on Patients 2
... ... special section dedicated to prescription sunglasses , ... New Jersey (PRWEB) May 26, 2010 -- With summer quickly ... in selling prescription glasses has been selling prescription sunglasses since ...
... appendicitis, but a patient,s symptoms are inconsistent with the ... or recurrent appendicitis and surgical treatment, according to a ... printed issue of the journal Radiology . ... results in missed appendicitis, with a possible increased risk ...
... medications should spur patient-doctor discussions, agency says, , TUESDAY, ... as Prevacid, Prilosec and Nexium will now carry a ... heightened risk for fractures, the U.S. Food and Drug ... consumers to use this class of medicines, called proton ...
... ... ... Shield of Massachusetts, Inc. (BCBSMA) and Northeast Health Systems Physician Hospital Organization, Inc. (NEPHO) ... marks the first North Shore physician group to adopt BCBSMA’s global payment model that is ...
... patient outcomes, researchers say , TUESDAY, May 25 (HealthDay ... obstructive pulmonary disease (COPD) do better when they receive ... patients who were given antibiotics early in their hospital ... less likely to have to be readmitted to the ...
... ... side-by-side this summer on extensive and collaborative research projects as part of Houghton College’s ... ... the Division of Math and Natural Science will work side-by-side this summer on extensive ...
Cached Medicine News:Health News:GlassesUSA.com Launches Section for Prescription Sunglasses 2Health News:Appendectomy may be best for patients with positive CT exam 2Health News:FDA Warns of Fracture Risk With Popular Heartburn Drugs 2Health News:FDA Warns of Fracture Risk With Popular Heartburn Drugs 3Health News:Blue Cross Blue Shield of Massachusetts and Northeast Health Systems Physician Hospital Organization Sign Alternative Quality Contract 2Health News:Blue Cross Blue Shield of Massachusetts and Northeast Health Systems Physician Hospital Organization Sign Alternative Quality Contract 3Health News:Blue Cross Blue Shield of Massachusetts and Northeast Health Systems Physician Hospital Organization Sign Alternative Quality Contract 4Health News:Quick Use of Antibiotics Best for COPD Flare-Ups 2Health News:Quick Use of Antibiotics Best for COPD Flare-Ups 3Health News:H1N1, Biodegradable Plastics and Nuclear Physics Highlight Research Areas Undertaken During Houghton College's Summer Research Institute 2Health News:H1N1, Biodegradable Plastics and Nuclear Physics Highlight Research Areas Undertaken During Houghton College's Summer Research Institute 3Health News:H1N1, Biodegradable Plastics and Nuclear Physics Highlight Research Areas Undertaken During Houghton College's Summer Research Institute 4Health News:H1N1, Biodegradable Plastics and Nuclear Physics Highlight Research Areas Undertaken During Houghton College's Summer Research Institute 5
(Date:8/29/2014)... 2014  United Therapeutics Corporation (NASDAQ: UTHR ... the District of New Jersey ... against Sandoz, Inc. regarding United Therapeutics, Remodulin ® ... that U.S. Patent No. 6,765,117 is both valid and ... its generic product until the expiration of that patent ...
(Date:8/29/2014)... , Aug. 29, 2014 Diseases largely eradicated ... generation ago are returning. Measles was declared eliminated in ... 2014 as of August 15—the highest incidence in 20 ... health department declared whooping cough a problem of ... getting sick and dying from these preventable diseases—in part ...
(Date:8/29/2014)... , Aug. 29, 2014 Research ... "Global Multiple Sclerosis Drugs Market 2014-2018" report ... a chronic, inflammatory medical condition that results in demyelination, ... because of an abnormal response by the immune system, ... It is a potentially debilitating disease in which the ...
Breaking Medicine Technology:District Court Decision Received In Remodulin Patent Case 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 3
... Approach to Blood ... Pressure Management, ... in the discovery and development of novel small,molecule therapeutics, announced ... statistically significant,blood pressure reductions in a Phase 2a study in ...
... MDVN ) today announced that data from an ... antagonist, MDV3100, will be presented,in an oral presentation at ... in Chicago., Session title: New Targeted Strategies ... time: Monday, June 2 at 11:30 a.m. Central Time ...
Cached Medicine Technology:Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 2Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 3Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 4Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 5Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 6Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 7Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 8Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 2Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 3
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Low-profile, hand-held instrument....
Low-profile, hand-held instrument....
Developed in conjunction with Pierce E. Scranton, Jr., M.D., the Seattle Small Joint Arthroscopy Set offers meticulously designed instrumentation for elbow, foot, and ankle surgeries....
Medicine Products: